Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine | Zendy

Dien Minh Vu | Zendy; Diep T B Vu | Zendy; T T Thuy | Zendy; Allison E Olmsted | Zendy; Bach H Dao | Zendy; Truc Thanh Thai | Zendy; Chi L. Nguyen | Zendy; Thi-Tuyet-Nhung Le | Zendy; Lê Anh Tuấn | Zendy; Hien Thu Bui | Zendy; Thach Ngoc Pham | Zendy; Matthew R. Moore | Zendy

Open Access

Presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies Among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine

Author(s) -

Dien Minh Vu,

Diep T B Vu,

T T Thuy,

Allison E Olmsted,

Bach H Dao,

Truc Thanh Thai,

Chi L. Nguyen,

Thi-Tuyet-Nhung Le,

Lê Anh Tuấn,

Hien Thu Bui,

Thach Ngoc Pham,

Matthew R. Moore

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac493

Subject(s) - medicine , dosing , vaccination , antibody , seroprevalence , adverse effect , immunology , population , cohort , covid-19 , prospective cohort study , serology , disease , environmental health , infectious disease (medical specialty)

Before the SARS-CoV-2 Delta variant arrived in Vietnam, case rates suggested seroprevalence of SARS-CoV-2 was low. Beginning in March 2021, we assessed different dosing schedules and adverse events following immunization (AEFIs) for ChAdOx1 nCoV-19 vaccine among healthcare workers (HCWs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research